What is the recommended dosage of metronidazole (Flagyl) for bacterial vaginosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Metronidazole Dosage for Bacterial Vaginosis

For non-pregnant women with bacterial vaginosis, take metronidazole 500 mg orally twice daily for 7 days, and completely avoid all alcohol during treatment and for at least 24 hours after the last dose. 1, 2

Standard Dosing Regimens

First-Line Treatment (Non-Pregnant Women)

  • Metronidazole 500 mg orally twice daily for 7 days is the CDC-recommended standard treatment, achieving high cure rates (78-87%) with systemic coverage 1, 2, 3
  • This 7-day oral regimen is more effective than single-dose alternatives and provides relief of symptoms with improvement in clinical course 2, 4

Alternative Oral Regimens

  • Metronidazole 2g orally as a single dose can be used, but has lower efficacy compared to the 7-day course and higher relapse rates 2, 4
  • Metronidazole extended-release (Flagyl ER) 750 mg once daily for 7 days is FDA-approved, though clinical equivalency data with other regimens is limited 2

Topical Alternatives

  • Metronidazole gel 0.75%, one full applicator (5g) intravaginally once daily for 5 days achieves less than 2% of blood levels compared to oral medication, minimizing systemic side effects like gastrointestinal upset and metallic taste 1, 2
  • The vaginal gel formulation is appropriate for patients who cannot tolerate systemic metronidazole due to gastrointestinal side effects 1

Pregnancy-Specific Dosing

Pregnant Women (All Trimesters After First)

  • Metronidazole 250 mg orally three times daily for 7 days is the CDC-recommended regimen for pregnant women, using a lower dose to minimize fetal exposure while providing systemic coverage 1, 2, 5
  • Metronidazole is safe during pregnancy after the first trimester, but metronidazole is contraindicated in the first trimester 1, 2
  • Alternative regimens include metronidazole 2g single dose or clindamycin 300 mg orally twice daily for 7 days 1
  • Avoid clindamycin vaginal cream in pregnancy as it may increase the risk of preterm deliveries 1

Critical Safety Warnings

Alcohol Interaction

  • Patients must completely avoid all alcoholic beverages during treatment and for at least 24 hours after completing the last dose to prevent severe disulfiram-like reactions 1, 2

Common Side Effects

  • Mild gastrointestinal upset and unpleasant metallic taste in mouth are common with oral metronidazole 1
  • The vaginal gel formulation avoids the metallic taste associated with oral therapy 1

Special Populations

HIV-Infected Patients

  • Use the same treatment regimens as for HIV-negative patients, including metronidazole 500 mg orally twice daily for 7 days or 250 mg three times daily for 7 days in pregnancy 1

Patients with Metronidazole Allergy

  • Clindamycin 2% vaginal cream, one full applicator (5g) intravaginally at bedtime for 7 days is the preferred first-line alternative, with cure rates of 72% 2, 3
  • Oral clindamycin 300 mg twice daily for 7 days achieves cure rates of 93.9%, comparable to metronidazole 2, 6
  • Never use metronidazole gel vaginally in patients with true metronidazole allergy, as true allergy requires complete avoidance of all metronidazole formulations 2

Clinical Pitfalls to Avoid

Treatment Failure Considerations

  • The bacterial vaginosis cure rate with standard metronidazole therapy is approximately 54-87%, with incomplete eradication of bacterial vaginosis-associated anaerobes in most women 3, 7
  • High pretreatment concentrations of pathobionts and vaginal microbiota dominated by Gardnerella vaginalis (>50%) are associated with increased likelihood of treatment failure 7
  • Recurrence rates approach 50% within one year of treatment, but no long-term maintenance regimen is currently recommended 1, 2

Partner Management

  • Sexual partners do not need treatment, as multiple clinical trials demonstrate that treating partners does not improve cure rates or prevent recurrence 1, 2, 5

Follow-Up

  • No follow-up visit is necessary if symptoms completely resolve 1, 2
  • If symptoms return, contact your provider for retreatment with a recommended regimen rather than self-treating with over-the-counter products 1

Contraceptive Interactions

  • Metronidazole gel does not weaken latex condoms or diaphragms, unlike clindamycin cream which is oil-based 1, 2

References

Guideline

Bacterial Vaginosis Treatment with Metronidazole

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Bacterial Vaginosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of sexually transmitted vaginosis/vaginitis.

Reviews of infectious diseases, 1990

Research

Bacterial vaginosis: review of treatment options and potential clinical indications for therapy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.